- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03573128
Development and Pilot Testing of the Students With Autism Accessing General Education (SAAGE) Model (SAAGE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Children subjects:
- Are enrolled in school grades kindergarten through 5th
- Have an IEP educational classification of Autism, confirmed by the Autism Diagnostic Observation Schedule, Second Edition, and DSM-5 checklist
- No planned changes in school placement or core team members during the school year of participation
Adult subjects (teachers, para educators):
- Instructional personnel who currently support a participating child with ASD at school (e.g., teacher, instructional assistant, speech pathologist, occupational therapist)
- Letter from instructional personnel's district or school indicating agreement to take part in the research project
Exclusion Criteria:
Children subjects • Diagnosis of (1) genetic disorders such as Fragile X, Down syndrome, or tuberous sclerosis; 2) profound vision or hearing loss; or (3) motor disabilities such as cerebral palsy (these multiple disabilities would prevent standard implementation of the intervention protocol).
Adult subjects
• Instructional personnel whose written consent was not obtained
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
Students with Autism Accessing General Education (SAAGE).
Teaching staff work with a study team coach to identify areas of concern for individual students, create goals and implement a modular behavioral intervention using an active teaching/feedback loop model.
|
With study team coach support, teacher implemented modules addressing student behavioral/academic goals.
|
ACTIVE_COMPARATOR: Enhanced Services As Usual
Teaching staff access in-service training sessions hosted by study team and are provided with print materials from which the modules for the active intervention were created.
|
Teaching staff access in-service presentations and print materials with no active study team coaching.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change in student function as measured by the Developmental Disability-Clinical Global Assessment Scale
Time Frame: baseline to end of school year (approx. 9 months)
|
The Developmental Disability-Clinical Global Assessment Scale ranges from 1-100 with 100 indicating superior functioning.
It assesses student function in a classroom setting.
|
baseline to end of school year (approx. 9 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean change in social communication and interaction as rated by child's teacher using the 30 item Social Skills Subscale of the Social Skills Improvement System
Time Frame: baseline to end of school year (approx. 9 months)
|
The Social Skills Improvement System, Social Skills Subscale is a 30 item measure of social communication and interaction using a 4 point Likert scale to rate the frequency of behaviors and a 3 point Likert scale to the the importance of each item.
|
baseline to end of school year (approx. 9 months)
|
Mean change in restricted and repetitive behavior as measured by the Children's Yale-Brown Obsessive-Compulsive Scales - PDD
Time Frame: baseline to end of school year (approx. 9 months)
|
The Children's Yale-Brown Obsessive-Compulsive Scales - PDD is a modified version of the Children's Yale-Brown Obsessive-Compulsive Scales which is adapted for use with children with ASD.
It is a semi structured clinician rated scale designed to rate the current severity of repetitive behavior.
Each item is scored on a 5 point scale from 0 to 4 with 4 being most symptomatic.
|
baseline to end of school year (approx. 9 months)
|
Change in teacher-nominated target behaviors
Time Frame: baseline to end of school year (approx. 9 months)
|
Teacher Nominated Target Behaviors
|
baseline to end of school year (approx. 9 months)
|
Change in on-task behavior during instruction
Time Frame: baseline to end of school year (approx. 9 months)
|
Academic Engaged Time
|
baseline to end of school year (approx. 9 months)
|
School-related adaptive functioning
Time Frame: baseline to end of school year (approx. 9 months)
|
Adaptive Behavior Assessment System, Self-Direction Scale
|
baseline to end of school year (approx. 9 months)
|
Social skills and behavior regulation
Time Frame: baseline to end of school year (approx. 9 months)
|
Social Skills Improvement System
|
baseline to end of school year (approx. 9 months)
|
Class placement
Time Frame: baseline to end of school year (approx. 9 months)
|
IEP review
|
baseline to end of school year (approx. 9 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tristram H Smith, PhD, University of Rochester
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R324A150032
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Students with Autism Accessing General Education
-
University of Missouri-ColumbiaUnited States Department of DefenseRecruitingAutism Spectrum Disorder | Insomnia ChronicUnited States
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | AutismUnited States
-
University of PaviaConsiglio per la ricerca in agricoltura e l'analisi dell'economia agraria...Not yet recruitingAutism Spectrum DisorderItaly
-
Saglik Bilimleri UniversitesiCompleted
-
Holland Bloorview Kids Rehabilitation HospitalRecruitingAutism Spectrum DisorderCanada
-
Bruno RhinerUniversity of Arkansas; West Virginia UniversityRecruiting
-
Brigham and Women's HospitalNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedFirst Degree Relatives of Rheumatoid Arthritis PatientsUnited States
-
University of MalagaAndaluz Health ServiceCompletedChronic DisordersSpain
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Australia, Canada, Puerto Rico